APA (7th ed.) Citation

F, M., E, L., S, N. M., I, S. d. l. C., L, Z., I, O., . . . J, B. (2025). Safety, tolerability, and immunogenicity of pentavalent meningococcal MenABCWY vaccine in healthy infants: A phase 2b randomized clinical trial. Human vaccines & immunotherapeutics, 21(1), 2463194. https://doi.org/10.1080/21645515.2025.2463194

Chicago Style (17th ed.) Citation

F, Martinon-Torres, et al. "Safety, Tolerability, and Immunogenicity of Pentavalent Meningococcal MenABCWY Vaccine in Healthy Infants: A Phase 2b Randomized Clinical Trial." Human Vaccines & Immunotherapeutics 21, no. 1 (2025): 2463194. https://doi.org/10.1080/21645515.2025.2463194.

MLA (9th ed.) Citation

F, Martinon-Torres, et al. "Safety, Tolerability, and Immunogenicity of Pentavalent Meningococcal MenABCWY Vaccine in Healthy Infants: A Phase 2b Randomized Clinical Trial." Human Vaccines & Immunotherapeutics, vol. 21, no. 1, 2025, p. 2463194, https://doi.org/10.1080/21645515.2025.2463194.